MAM
Monaco Asset Management’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $756K | Sell |
675,000
-474,708
| -41% | -$532K | 0.13% | 60 |
|
|
2025
Q1 | $908K | Buy |
1,149,708
+822,037
| +251% | +$649K | 0.19% | 45 |
|
|
2024
Q4 | $541K | Buy |
327,671
+190,000
| +138% | +$314K | 0.08% | 57 |
|
|
2024
Q3 | $482K | Sell |
137,671
-149,229
| -52% | -$522K | 0.07% | 52 |
|
|
2024
Q2 | $941K | Sell |
286,900
-29,905
| -9% | -$98.1K | 0.15% | 39 |
|
|
2024
Q1 | $2.33M | Sell |
316,805
-1,866,423
| -85% | -$13.7M | 0.7% | 22 |
|
|
2023
Q4 | $8.17M | Buy |
2,183,228
+335,284
| +18% | +$1.25M | 2.4% | 10 |
|
|
2023
Q3 | $3.92M | Buy |
1,847,944
+842,718
| +84% | +$1.79M | 1.16% | 14 |
|
|
2023
Q2 | $4.78M | Buy |
1,005,226
+34,933
| +4% | +$166K | 1.34% | 14 |
|
|
2023
Q1 | $5.53M | Buy |
970,293
+720,293
| +288% | +$4.11M | 1.7% | 11 |
|
|
2022
Q4 | $2.52M | Buy |
+250,000
| New | +$2.52M | 0.76% | 32 |
|